Nu Skin Enterprises, Inc. (NYSE:NUS) Director Sells $20,349.86 in Stock

Nu Skin Enterprises, Inc. (NYSE:NUS) Director Edwina D. Woodbury sold 1,693 shares of Nu Skin Enterprises stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $12.02, for a total value of $20,349.86. Following the completion of the transaction, the director now owns 18,095 shares of the company’s stock, valued at $217,501.90. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Nu Skin Enterprises Price Performance

Nu Skin Enterprises stock opened at $12.41 on Monday. The company has a current ratio of 2.13, a quick ratio of 1.28 and a debt-to-equity ratio of 0.58. The company has a fifty day simple moving average of $12.66 and a 200-day simple moving average of $16.02. The stock has a market cap of $613.30 million, a P/E ratio of 68.95 and a beta of 1.13. Nu Skin Enterprises, Inc. has a 12-month low of $11.73 and a 12-month high of $39.38.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Wednesday, February 14th. The company reported $0.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.29 by $0.08. Nu Skin Enterprises had a return on equity of 10.73% and a net margin of 0.44%. The company had revenue of $488.64 million during the quarter, compared to the consensus estimate of $479.35 million. Equities analysts expect that Nu Skin Enterprises, Inc. will post 1.13 EPS for the current fiscal year.

Nu Skin Enterprises Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 6th. Shareholders of record on Monday, February 26th were issued a dividend of $0.06 per share. The ex-dividend date was Friday, February 23rd. This represents a $0.24 dividend on an annualized basis and a yield of 1.93%. Nu Skin Enterprises’s payout ratio is currently 133.34%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Invesco Ltd. lifted its position in Nu Skin Enterprises by 91.8% in the third quarter. Invesco Ltd. now owns 1,694,112 shares of the company’s stock valued at $35,932,000 after acquiring an additional 810,778 shares during the last quarter. Norges Bank purchased a new stake in shares of Nu Skin Enterprises in the 4th quarter valued at about $8,930,000. Federated Hermes Inc. boosted its position in shares of Nu Skin Enterprises by 29,649.3% in the 4th quarter. Federated Hermes Inc. now owns 330,812 shares of the company’s stock valued at $6,424,000 after purchasing an additional 329,700 shares during the period. Victory Capital Management Inc. grew its stake in Nu Skin Enterprises by 66.4% during the 3rd quarter. Victory Capital Management Inc. now owns 460,697 shares of the company’s stock worth $9,771,000 after buying an additional 183,769 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. increased its position in Nu Skin Enterprises by 17.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,157,697 shares of the company’s stock worth $22,482,000 after buying an additional 173,193 shares during the period. Institutional investors and hedge funds own 82.84% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com cut Nu Skin Enterprises from a “buy” rating to a “hold” rating in a research note on Saturday, February 24th. Four equities research analysts have rated the stock with a hold rating, According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $23.67.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.